Systematic Reviews
Copyright ©The Author(s) 2023.
World J Meta-Anal. Dec 18, 2023; 11(7): 351-367
Published online Dec 18, 2023. doi: 10.13105/wjma.v11.i7.351
Table 1 Baseline features in 59 patients with colitis induced by polystyrene
Variable
Patients, n = 59 (100%)
Mean age (yr) (SD)60.6 ± 16.6
Sex (male)35 (60.3)
Signals and symptoms
Abdominal pain35 (60.3)
Bloating18 (31)
Hematochezia18 (31)
Constipation7 (12)
Diarrhea7 (12)
Hypotension6 (10.3)
Melena4 (6.9)
Fatigue4 (6.9)
Fever4 (6.9)
Vomiting4 (6.9)
Pneumoperitoneum3 (5.1)
Gastrointestinal involvement
Cecum18 (31)
Rectum15 (25.8)
Small intestine13 (22.4)
Transverse colon10 (17.2)
Ascendent colon9 (15.5)
Sigmoid9 (15.5)
Descendent colon8 (13.7)
Pancolitis3 (5.1)
Stomach2 (3.4)
Mean potassium levels (mmol/L) (SD)6.5 ± 0.98
Comorbidities
Chronic kidney disease37 (63.7)
Hypertension20 (34.4)
Type 2 diabetes12 (20.6)
Peripheral arterial disease7 (12)
Coronary artery disease6 (10.3)
Polystyrene type
Calcium (Kalimate)11 (18.9)
Sodium (Kayexalte)47 (81)
Mean polystyrene dose (g) (SD)83.6 ± 70
Administration route
Per os38 (65.5)
Retal5 (8.6)
Per os and retal3 (5.1)
Mean time of onset symptoms (d) (SD)5.5 ± 6.9
Biopsy51 (87.9)
Treatment
Surgery29 (50)
Outcomes
Recovery39 (67.2)
Death12 (20.6)
Mean time to outcome (d) (SD)36.7 ± 35.5